Muhlenkamp & CO Inc Jazz Pharmaceuticals PLC Transaction History

Muhlenkamp & CO Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Aug 18, 2021	SELL	$150.19 - $173.5 $7.58 Million - $8.75 Million	-50,460 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$140.71 - $165.05 $29,971 - $35,155	213 Added 0.42%	50,460 $8.33 Million
Q3 2020 Nov 13, 2020	BUY	$105.46 - $144.13 $51,042 - $69,758	484 Added 0.97%	50,247 $7.17 Million
Q2 2020 Aug 20, 2020	BUY	$95.68 - $121.88 $13,108 - $16,697	137 Added 0.28%	49,763 $5.49 Million
Q4 2019 Feb 20, 2020	BUY	$117.65 - $153.73 $1.57 Million - $2.06 Million	13,384 Added 36.93%	49,626 $7.41 Million

Q3 2019 Nov 27, 2019	BUY	$125.18 - $143.24 $4,882 - $5,586	39 Added 0.11%	36,242 $4.64 Million
Q2 2019 Aug 28, 2019	SELL	$125.55 - $144.48 $15,191 - $17,482	-121 Reduced 0.33%	36,203 $5.16 Million
Q1 2019 May 23, 2019	SELL	$121.81 - $142.95 $78,811 - $92,488	-647 Reduced 1.75%	36,324 $5.19 Million
Q3 2018 Nov 13, 2018	SELL	$161.01 - $180.57 $29,625 - $33,224	-184 Reduced 0.5%	36,971 $6.22 Million
Q2 2018 Aug 13, 2018	BUY	$146.33 - $183.18 $5.44 Million - $6.81 Million	37,155 New	37,155 $6.4 Million

515

57M

65.9K

183K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $6.3B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Muhlenkamp & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Muhlenkamp & CO Inc with notifications on news.